(Q53256610)

English

Clinical evaluation of QT/QTc prolongation and proarrhythmic potential for nonantiarrhythmic drugs: the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use E14 guideline.

scientific article published in May 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16638733

Clinical evaluation of QT/QTc prolongation and proarrhythmic potential for nonantiarrhythmic drugs: the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use E14 guideline. (English)

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16638733

author name string

Borje Darpo

1

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16638733

Thierry Nebout

2

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16638733

Philip T Sager

3

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16638733

publication date

1 May 2006

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16638733

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16638733

46

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16638733

5

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16638733

498-507

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16638733

The significance of QT interval in drug development

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286436

21 January 2018

Arrhythmogenic mechanisms of non-sedating antihistamines

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286436

21 January 2018

Drug induced QT prolongation and torsades de pointes

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286436

21 January 2018

Spontaneous adverse event reports of serious ventricular arrhythmias, QT prolongation, syncope, and sudden death in patients treated with cisapride

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286436

21 January 2018

Effects of a single oral dose of sparfloxacin on ventricular repolarization in healthy volunteers

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286436

21 January 2018

The influence of cisapride and clarithromycin on QT intervals in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286436

21 January 2018

Effects of three fluoroquinolones on QT interval in healthy adults after single doses

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286436

21 January 2018

Moxifloxacin does increase the corrected QT interval

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286436

21 January 2018

Comparing methods of measurement for detecting drug-induced changes in the QT interval: implications for thoroughly conducted ECG studies.

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286436

21 January 2018

Electrocardiographic identification of drug-induced QT prolongation: assessment by different recording and measurement methods.

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286436

21 January 2018

Modulation of QT interval during autonomic nervous system blockade in humans

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286436

21 January 2018

Effect of single and repeated oral doses of telithromycin on cardiac QT interval in healthy subjects

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286436

21 January 2018

QTc interval (cardiac repolarization): lengthening after meals.

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286436

21 January 2018

Inter- and intraday variability in major electrocardiogram intervals and amplitudes in healthy men and women

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286436

21 January 2018

Electrocardiographic and clinical predictors of torsades de pointes induced by almokalant infusion in patients with chronic atrial fibrillation or flutter: a prospective study.

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286436

21 January 2018

Evaluation of drug-induced QT interval prolongation: implications for drug approval and labelling

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286436

21 January 2018

Problems of heart rate correction in assessment of drug-induced QT interval prolongation.

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286436

21 January 2018

Relation between QT and RR intervals is highly individual among healthy subjects: implications for heart rate correction of the QT interval

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286436

21 January 2018

Clinical assessment of drug-induced QT prolongation in association with heart rate changes

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286436

21 January 2018

Assessment of drug-induced QT prolongation: to bin or not to bin?

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286436

21 January 2018

Terfenadine-associated ventricular arrhythmias and QTc interval prolongation. A retrospective cohort comparison with other antihistamines among members of a health maintenance organization

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286436

21 January 2018

Effect of a single oral dose of moxifloxacin (400 mg and 800 mg) on ventricular repolarization in healthy subjects

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286436

21 January 2018

Dose-response relation between terfenadine (Seldane) and the QTc interval on the scalar electrocardiogram: distinguishing a drug effect from spontaneous variability

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286436

21 January 2018

Cisapride and fatal arrhythmia

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286436

21 January 2018

Drug-induced prolongation of the QT interval: why the regulatory concern?

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286436

21 January 2018

Drug-induced prolongation of the QT interval: regulatory dilemmas and implications for approval and labelling of a new chemical entity

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286436

21 January 2018

Repeated consumption of grapefruit juice considerably increases plasma concentrations of cisapride

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286436

21 January 2018

Within-subject electrocardiographic differences at equal heart rates: role of the autonomic nervous system

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286436

21 January 2018

Computer-based analysis of dynamic QT changes: toward high precision and individual rate correction

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286436

21 January 2018

The risk of serious cardiac arrhythmias among cisapride users in the United Kingdom and Canada

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286436

21 January 2018

Identifiers

10.1177/0091270006286436

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16638733

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16638733

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53256610&oldid=2081493020"